BACKGROUND Noninvasive techniques to assess subclinical spread of nonmelanoma skin cancer (NMSC) may improve surgical precision. High-resolution ultrasound has shown promise in evaluating the extent of NMSC.
C ollectively referred to as nonmelanoma skin cancer (NMSC), basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) affect more than 1 million individuals in the United States every year. 1, 2 NMSC consumes substantial health care expenditures, 3 impairs health-related quality of life, 4 and may lead to significant cosmetic and functional impairment.
With proper tumor selection and physician experience, nonexcisional and excisional treatment modalities can achieve high cure rates for NMSC. 5, 6 Standard excision or Mohs micrographic surgery is indicated when the risk of recurrence or metastases is high because of large tumor size; location on the head and neck, genitalia, or hands and feet; history of prior treatment; or aggressive histology. 7 For any method of excision, the initial determination of an appropriate surgical margin starts with an accurate assessment of the clinical extent of the tumor. High rates of subclinical spread associated with BCC and SCC frequently make visualization and palpation unreliable to determine tumor extent. 8, 9 Mohs micrographic surgery addresses this dilemma with complete histologic examination of the surgical cut edge, which allows detection of areas of subclinical tumor extension, and with a meticulous method of tumor mapping, which allows selective excision of subclinical tumor remnants. Despite its high cure rates and optimal tissue sparing, economic and practical matters preclude treatment of all high-risk NMSC with Mohs surgery.
More accurate preoperative assessment of tumor boundaries has important implications for improving care of patients with NMSC. Improved preoperative assessment may facilitate triaging of patients with high-risk NMSC to standard excision or Mohs surgery. Health care costs may decline, because a decrease in the incidence of positive margins after standard excision and a decrease in the number of stages with Mohs surgery might be expected. Patients may benefit from improved cosmetic and functional outcomes by preventing excision of clinically equivocal areas that are shown preoperatively not to involve tumor.
High-resolution ultrasound shows promise as a diagnostic test to improve preoperative delineation of the clinical margins of NMSC. In recent studies, highresolution ultrasound has been shown to reliably determine the depth of BCC. 10, 11 The clinical usefulness of ultrasound in predicting margins of NMSC has not been examined. The purpose of this study was to examine the accuracy of high-resolution ultrasound to assess margins preoperatively in patients with NMSC undergoing Mohs surgery.
Methods

Study Design
The University of Pennsylvania Institutional Review Board approved this study. A cross-sectional study was performed in 100 consecutive patients who met the inclusion and exclusion criteria and provided consent to study participation.
Study Population and Inclusion/Exclusion Criteria
Patients aged 18 to 95 with a biopsy-proven invasive SCC or BCC were enrolled. Patients were excluded if the tumor was confined to the epidermis (e.g., SCC in situ and superficial BCC) or was located in an anatomic area that was difficult to image with the ultrasound probe (e.g., ear, nasal ala, or inner canthus), the surgeon was unable to visualize the tumor on clinical examination, or the patient had undergone surgery (e.g., electrodesiccation and curettage, surgical excision) with the intent to remove the tumor within the previous 6 months. 
Study Procedures
Data Analysis
The sample size of 100 patients was determined based on predicted correct classification of 80%. This study was powered to estimate a correct classification with a precision of 7 8 based on the 95% confidence interval. Power and sample size were determined using Stata v9.0 (Stata Corp., College Station, TX).
If tumor extension was seen on ultrasound and histology, the Mohs surgeon compared the Mohs and ultrasound diagrams to determine whether the location of tumor extension correlated precisely. A case was considered to be a true positive if ultrasound and histology were positive in the same location. A case was considered to be a false positive if tumor was detected on ultrasound but not on histopathologic evaluation of the Mohs margins. A case was considered to be a false negative if it was negative on ultrasound but positive histologically or if it was positive on ultrasound but not in the same location as the histologically positive area. A case was counted as a true negative when the ultrasound and histology were both negative. 
Results
Of the 112 patients that were eligible to participate in the study, 100 consented to study participation, resulting in an 89% participation rate. If a patient presented with more than one tumor, the Mohs surgeon selected the largest tumor as the index case, which was imaged in this study. Thus, only one tumor per patient underwent ultrasonographic margin evaluation. Figure 1 illustrates an example of a tumor photograph taken using ultra-sound. In two cases, the Mohs surgeon elected to take a second layer because of the presence of histologic tumor remnants located outside the dyed edges of the Mohs tissue section. Because it was suspected that these histologic tumor remnants represented a false-positive margin due to artifact from tissue processing (floaters), these cases were eliminated from the study. Consequently, 98 cases were left for analysis. ). Twenty-six percent (n = 25) of cases were positive histologically. Five of these cases were positive in the subcutaneous fat, and nine were positive in the epidermis only. Ten were positive in the dermis, and one was positive in the dermis and subcutaneous fat.
Patients were classified based on interpretation of ultrasound and histology ( Table 2 ). The overall test characteristics comparing the ultrasonographic margin evaluation with histopathology are as follows: sensitivity = 32% (95% confidence interval (CI) = 15-54), specificity = 88% (95% CI = 78-94), positive predictive value = 47, negative predictive value = 79, correct classification = 0.73 (Table 3) . In this study, the prevalence of positive histologic margins was 0.26.
In subgroup analyses, there were no significant differences in the performance of the ultrasound 
according to tumor histology, patient age, sex, or location. Additionally, there was no improvement in sensitivity over the course of the study (data not shown). The ultrasound was more sensitive for larger (area above the median of 1.74 cm 2 ) than smaller tumors (sensitivity = 55%).
As a qualitative analysis, Mohs slides of the true positive and false negative cases were reviewed to determine whether differences in tumor characteristics existed between cases in which ultrasound correctly identified tumor (true positives) and cases in which ultrasound failed to identify tumor (false negatives). In cases in which the ultrasound correctly identified histologic tumor extension (true positives), the areas of extension were usually in the superficial papillary dermis and were fairly pronounced. Figure 2 represents a Mohs slide and correlated ultrasound image of a true positive case. Of the 17 cases in which ultrasound failed to identify histologic tumor extension (false negatives), 11 cases had tumor extension in the epidermis or fat, five cases had infiltrative or morpheaform BCC histology (Figure 3 ), and one case was a nodular BCC with extension in the dermis. 
Discussion
The test characteristics of the high-resolution ultrasound determined in this study were not found to be clinically useful. The low overall sensitivity (32%) resulted in part from the optical limitations of the device used in this study and limitations of the study design. The ultrasound is optimized to image the dermis with greater resolution than the epidermis and thus was expected to provide less accurate imaging of the epidermis. Although the ultrasound has potential to visualize tumor in the subcutaneous tissue (deep margin), this study was designed only to compare peripheral margins of the ultrasound with histopathology. We chose not to assess the deep margins of the tumor with ultrasound because the ultrasound technician would not be able to know how deep the surgeon would excise the tumor and thus would not be able to determine whether there was tumor outside the surgeon's first-stage surgical margin. In the qualitative analysis, 65% (11/17) of false negative cases were positive and had histologic tumor remnants in the epidermis or fat. Excluding these tumors with subclinical extension in the epidermis or subcutaneous fat, sensitivity improved from 32% to 56%, a number still too low for clinical application.
When analysis was limited to larger tumors (those with clinical areas greater than the median of 1.74 cm 2 ) with histologically positive margins only in the dermis (n = 44), sensitivity of ultrasound was 80% (95% CI = 28-99) and specificity 84% (95% CI = 69-94) ( Table 3 ). The wide CI around the sensitivity analysis limits its interpretation, although it appears that ultrasound has the potential to predict margins of larger tumors with subclinical dermal involvement with reasonable accuracy. This finding suggests that ultrasound may be successful in predicting margins of all NMSC as the technology improves.
The characteristics of our study population should be generalizable to populations seen in most Mohs surgery clinics in the United States. The three to one ratio of BCC to SCC in our study is similar to other reports on the epidemiology of NMSC. 1 Comparable with previous reports, 26% of cases in our study required two or more stages for tumor clearance.
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Spectrum bias is unlikely, because we enrolled 100 consecutive patients who met our inclusion criteria without regard to disease severity. Verification bias is also unlikely, because we compared ultrasound directly with the criterion standard (histopathology) in 98% of cases.
Failure of high-resolution ultrasound to detect subclinical tumor margins may have been the result of several reasons. First, operator error and incorrect ultrasound interpretation may have prevented accurate assessment of tumor extension. This scenario is unlikely, because test characteristics did not improve in the later stages of the study, when greater experience of the ultrasound technologist could arguably have led to better ultrasound skills. Second, scar tissue, severe solar elastosis, and inflammation, features very common around tumor sites, produce ultrasound images that are difficult to distinguish from tumor ( Figure 4) . Additionally, the machine as used in this study lacked the resolution necessary to accurately visualize tumor in the epidermis, and the study did not assess ultrasound performance in the subcutaneous tissue. In our study, 15 of the 98 included cases (15.3%) had extension in the epidermis or subcutaneous fat, which the ultrasound was ill suited to detect. Finally, the ultrasound device failed to detect subclinical tumor in the dermis for six cases. Of these six cases, five tumors exhibited BCC with infiltrative or morpheaform histology in the dermis. Because these represent histologic subtypes for which ultrasound would have great potential utility to examine subclinical extent, it was disappointing that the device did not image small tumor extensions with reliability.
Conclusions
Noninvasive techniques to improve preoperative assessment of tumor extent have potential to increase the efficiency of surgical therapy and decrease costs associated with NMSC. In our study population, high-resolution ultrasound failed to detect subclinical tumor extensions with accuracy. The utility of high-resolution ultrasound will depend on technological improvements that allow high-resolution images of the epidermis, subcutaneous fat, and small tumor strands in the dermis. Higher-resolution images must also allow one to distinguish dermal tumor from scar, severe solar elastosis, and inflammation, which frequently accompany NMSC.
optical coherence tomography (OCT), confocal microscopy (CM) in reflectance or fluorescence mode, and high-frequency ultrasound.
In this study, the authors used high-frequency ultrasound with a transducer at 40 MHz to investigate its usefulness in assessing tumor borders before surgical excisions by comparing with conventional light microscopy, the standard of care. The potential benefit of this study is to use this device to better delineate the clinical margins for surgical excision or first-stage excision of Mohs surgery. The investigators recruited 100 patients for the study. The design and the statistical analysis were well executed, and the results of this investigation showed sensitivity and specificity of 32% and 88%, respectively. The ultrasound had difficulty distinguishing smaller tumors, tumors in the epidermis, and tumors in subcutaneous fat. It is evident from the results that this device at its current state is not useful clinically. As with the other new noninvasive skin imaging devices (OCT and CM), one of the greatest challenges for researchers is to fine tune the device to be able to distinguish smaller tumors from the surrounding normal tissue. Until any imaging device is able to attain sensitivity and specificity close to the current standard of care, it would be difficult to incorporate these devices into our routine practice of surgical dermatology.
Nonetheless, it is encouraging to know that there are many prototypes, including the one used in this study, in the pipeline for noninvasive cutaneous imaging technology.
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